Bayern Munich's Jamal Musiala Reveals Neurological Absence Seizure Diagnosis Following Recent Match Collapses

Bayern Munich star Jamal Musiala has been battling a neurological issue for at least a year, club officials revealed after the midfielder collapsed during consecutive games. AP News reports that board member Max Eberl and coach Vincent Kompany confirmed the long-standing condition. A change in Musiala's treatment triggered the recent collapses, which alarmed teammates, opponents, and fans.
Musiala posted on Instagram that doctors diagnosed him with "absence seizures caused by a neurological dysfunction" but said he plans to keep playing. Winnipeg Free Press notes Kompany benched the 21-year-old from Bayern's German Supercup match to reduce pressure on the player during his recovery.
Bayern Munich knew about Musiala's neurological condition far longer than fans realized. Daily Item reports the club was aware of the issue for at least 12 months. The player managed his condition quietly until recent weeks, when treatment adjustments led to visible on-field incidents that forced the club to go public.
The crisis erupted when doctors altered Musiala's medical treatment. Houston Chronicle reports the adjustment to his regimen directly caused the collapses during multiple matches over one week. The sudden physical episodes shocked spectators and created urgent safety concerns for the young star's health on the pitch.
Musiala's diagnosis centers on absence seizures—brief episodes where consciousness fades for seconds. LMT Online confirms the seizures stem from a neurological dysfunction in his brain. These episodes differ from convulsive seizures; the player goes blank momentarily but remains upright, making them dangerous in fast-paced sports like football.
Despite his diagnosis, the 21-year-old midfielder refused to step away from the game. Herald Bulletin reports Musiala declared his intention to continue playing at his normal level. Kompany's decision to rest him for the German Supercup aims to stabilize his treatment and ease his return to full squad participation without added stress.
Publishers
8
Articles
7
Reach
8